Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups-Reference-Cited by-同舟云学术

Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups

Published:2023-10 Issue:2 Volume:117 Page:321-332
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Macchia Gabriella^ORCID,Pezzulla Donato^ORCID,Campitelli Maura,Laliscia Concetta,Fodor Andrei,Bonome Paolo,Draghini Lorena,Ippolito Edy,De Sanctis Vitaliana,Ferioli Martina,Titone Francesca,Balcet Vittoria,Di Cataldo Vanessa,Russo Donatella,Vicenzi Lisa,Cossa Sabrina,Lucci Simona,Cilla Savino,Deodato Francesco,Gambacorta Maria Antonietta,Scambia Giovanni,Morganti Alessio Giuseppe,Ferrandina Gabriella

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference33 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2019

2. Two pathogenetic types of endometrial carcinoma;Bokhman;Gynecol Oncol,1983

3. Recurrent endometrial cancer: Which is the best treatment? Systematic review of the literature;Restaino;Cancers (Basel),2022

4. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document;Lievens;Radiother Oncol,2020

5. Role of stereotactic body radiotherapy in gynecologic radiation oncology;Shenker;Int J Gynecol Cancer,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer;Clinical and Translational Radiation Oncology;2024-07

3. Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed;Health and Technology;2024-05-01

4. Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer;Gynecologic Oncology;2024-05

5. The clinical roadmap in a dual-beam hadrontherapy centre: tumour-based and patient-tailored selection criteria, management of range uncertainties and oncological patient pathway;Health and Technology;2024-04-19